Cue Biopharma, Inc.

8-K Director or officer change Aug 3, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Jul 10, 2026 8-K Director or officer change; Shareholder vote results Jun 3, 2026 8-K Director or officer change; Other events Jun 2, 2026 8-K May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events May 1, 2026 8-K Modified rights of security holders; Amended charter or bylaws Apr 22, 2026 8-K Shareholder vote results Apr 13, 2026 8-K Other events Apr 7, 2026 8-K Director or officer change Mar 27, 2026 8-K Results of operations (earnings release) Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Other events Feb 18, 2026 8-K Director or officer change Feb 12, 2026 8-K Entered a material agreement; Other events Dec 19, 2025 8-K Regulation FD disclosure Nov 24, 2025 8-K Director or officer change Nov 20, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Nov 6, 2025 8-K Director or officer change Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Entered a material agreement Jul 1, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 10, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Entered a material agreement; Results of operations (earnings release); Other events Apr 15, 2025 8-K Entered a material agreement Apr 14, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Director or officer change Mar 12, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Amended charter or bylaws; Shareholder vote results Oct 8, 2024 8-K Entered a material agreement Oct 4, 2024 8-K Entered a material agreement; Other events Sep 27, 2024 8-K Director or officer change Sep 3, 2024 8-K Delisting notice or listing-rule failure Aug 16, 2024